Alliance Pharma PLC Directorate Change (0570F)
February 17 2015 - 2:00AM
UK Regulatory
TIDMAPH
RNS Number : 0570F
Alliance Pharma PLC
17 February 2015
For immediate release 17 February 2015
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Directorate Change
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical
company, announces that Richard Wright has informed the Board of
his intention to leave the Company, after nearly eight years as
Finance Director, to pursue other opportunities. Richard will
remain in his role until 31 May 2015.
A search process for a new Finance Director has commenced and
the Company will provide an update on this in due course.
John Dawson, Alliance Pharma's Chief Executive, commented: "I
have enjoyed working with Richard and warmly thank him for the very
significant contribution he has made to Alliance's development over
these past several years. On behalf of the entire Board I wish him
well with his future endeavours."
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
Buchanan + 44 (0) 20 7466 5000
Mark Court / Sophie Cowles / Jane
Glover
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade /
Freddie Barnfield
Corporate Broking: David Poutney
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has a strong track record of acquiring the rights to
established niche products and owns or licenses the rights to more
than 60 pharmaceutical products and continues to explore
opportunities to expand the range.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAFMGMZNVFGKZM
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024